Company / Assets per Share
Stoke Therapeutics, Inc. Assets per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$7.74
FY2025
5-year range
$5.79 / $7.74
FY2021-FY2025
Trend
+30.9%
vs FY2024
Sector context
#118 of 210
Health Care
What the data says
At $7.74, Stoke Therapeutics, Inc.'s assets per share ranks #118 of 210 in the Health Care sector. Assets per Share has fluctuated over the past 8 years, ranging from $5.79 in FY2023 to $151.61 in FY2018.
Based on SEC 10-K filings.
7.74 in FY2025 with a 5-year CAGR of -2.7%.
Improved from $5.79 to $7.74 over the past 2 years.
Health Care sector context is included.
Assets per Share over time
Growth rates
- 3-Year CAGR
- +3.7%
- 5-Year CAGR
- -2.7%
- 10-Year CAGR
- -
Sector benchmark
#118 of 210 in Health CareTop 56% of 210This company $7.74 Sector average $353.15
▼
-97.8% below sector average
Key checks
Key Insights
- In FY2025, assets per share increased 30.9% year-over-year.
- Ranks #118 out of 210 companies in the Health Care sector.
- Peak assets per share was recorded in FY2018.
- Lowest assets per share in the period was in FY2023.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $7.74 | +30.9% |
| FY2024 | $5.91 | +2.1% |
| FY2023 | $5.79 | -16.6% |
| FY2022 | $6.94 | +6.7% |
| FY2021 | $6.50 | -26.9% |
| FY2020 | $8.90 | -30.1% |
| FY2019 | $12.73 | -91.6% |
| FY2018 | $151.61 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026